Improved antisaccade performance in schizophrenia with risperidone

Hutton, S. B.
April 2002
Journal of Neurology, Neurosurgery & Psychiatry;Apr2002, p429
Academic Journal
No abstract available.


Related Articles

  • Pharmacological Studies of Smooth Pursuit and Antisaccade Eye Movements in Schizophrenia: Current Status and Directions for Future Research. Ettinger, Ulrich; Kumari, Veena // Current Neuropharmacology;Dec2003, Vol. 1 Issue 4, p285 

    Smooth pursuit (SPEM) and antisaccade eye movements have been studied to elucidate the genetics and the pathophysiology of schizophrenia. In recent years, a rapidly growing literature has emerged on pharmacological influences on eye movements. This review focuses on pharmacological studies of...

  • Non-cholinergic modulation of antisaccade performance: a modafinil-nicotine comparison. Rycroft, N.; Hutton, S. B.; Clowry, O.; Groomsbridge, C.; Sierakowski, A.; Rusted, J. M. // Psychopharmacology;Dec2007, Vol. 195 Issue 2, p245 

    The antisaccade task provides a powerful tool with which to investigate the cognitive and neural systems underlying goal-directed behaviour, particularly in situations when the correct behavioural response requires the suppression of a prepotent response. Antisaccade errors (failures to suppress...

  • Effect of Transcranial Direct Current Stimulation on Prefrontal Inhibition in Schizophrenia Patients with Persistent Auditory Hallucinations: A Study on Antisaccade Task Performance. Subramaniam, Aditi; Agarwal, Sri Mahavir; Kalmady, Sunil; Shivakumar, Venkataram; Chhabra, Harleen; Bose, Anushree; Damodharan, Dinakaran; Narayanaswamy, Janardhanan C.; Hutton, Sam B.; Venkatasubramanian, Ganesan // Indian Journal of Psychological Medicine;Oct-Dec2015, Vol. 37 Issue 4, p419 

    Background: Deficient prefrontal cortex inhibitory control is of particular interest with regard to the pathogenesis of auditory hallucinations (AHs) in schizophrenia. Antisaccade task performance is a sensitive index of prefrontal inhibitory function and has been consistently found to be...

  • Schizophrenia and Related Disorders.  // Current Medical Literature: Psychiatry;2006, Vol. 17 Issue 1, p14 

    Presents abstracts of psychiatric research on schizophrenia and related disorders. "Lack of Association Between Prepulse Inhibition and Antisaccadic Deficits in Chronic Schizophrenia: Implications for Identification of Schizophrenia Endophenotypes"; "P50 Suppression in Individuals at Risk for...

  • Risperidone.  // Reactions Weekly;6/20/2009, Issue 1257, p38 

    The article describes the case of a 27-year-old man who developed severe erectile dysfunction after being treated with risperidone for paranoid schizophrenia. The man stopped taking risperidone after three months and was prescribed tadalafil. His sexual performance improved, as well as his...

  • Antisaccade performance in schizophrenia: a neural model of decision making in the superior colliculus. Cutsuridis, Vassilis; Kumari, Veena; Ettinger, Ulrich // Frontiers in Neuroscience;Feb2014, Vol. 8, p1 

    Antisaccade performance deficits in schizophrenia are generally interpreted as an impaired top-down inhibitory signal failing to suppress the erroneous response. We recorded the antisaccade performance (error rates and latencies) of healthy and schizophrenia subjects performing the mirror...

  • Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy. Schmechtig, Anne; Lees, Jane; Grayson, Lois; Craig, Kevin; Dadhiwala, Rukiya; Dawson, Gerard; Deakin, J.; Dourish, Colin; Koychev, Ivan; McMullen, Katrina; Migo, Ellen; Perry, Charlotte; Wilkinson, Lawrence; Morris, Robin; Williams, Steve; Ettinger, Ulrich // Psychopharmacology;May2013, Vol. 227 Issue 2, p331 

    Rationale: The increasing demand to develop more efficient compounds to treat cognitive impairments in schizophrenia has led to the development of experimental model systems. One such model system combines the study of surrogate populations expressing high levels of schizotypy with oculomotor...

  • Risperidone.  // Reactions Weekly;2/25/2006, Issue 1090, p23 

    Presents a case report on risperidone-induced hepatitis in a 28-year-old man. Effects of risperidone for paranoid schizophrenia on the patient according to investigations; Improvement in the condition of the patient after risperidone was discontinued.

  • Schizophrenia Medication Effective for Disruptive Behavior in Children.  // Psychiatric Annals;Jan2005, Vol. 35 Issue 1, p25 

    Reports on a study which found that the schizophrenia drug risperidone is safe and effective for the treatment of disruptive behavior in children with developmental disorders. Effect of risperidone on the irritability of children; Percentage of participants who showed improvement in their...

  • Long-acting injectable risperidone improves quality of life in schizophrenic patients: a clinical case series. Castro-Costa, Erico; de Castro Andrade, João Marcos; Quites, Lucas // Revista Brasileira de Psiquiatria;dez2008, Vol. 30 Issue 4, p403 

    A letter to the editor is presented about the efficacy of long-acting injectable risperidone in improving the quality of life in schizophrenia patients.


Read the Article


Sign out of this library

Other Topics